[go: up one dir, main page]

AU4373197A - Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof - Google Patents

Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof

Info

Publication number
AU4373197A
AU4373197A AU43731/97A AU4373197A AU4373197A AU 4373197 A AU4373197 A AU 4373197A AU 43731/97 A AU43731/97 A AU 43731/97A AU 4373197 A AU4373197 A AU 4373197A AU 4373197 A AU4373197 A AU 4373197A
Authority
AU
Australia
Prior art keywords
composition
same
single chain
directed against
chain antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43731/97A
Inventor
Andre Darveau
Yves Fradet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnocure Inc
Original Assignee
Diagnocure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnocure Inc filed Critical Diagnocure Inc
Publication of AU4373197A publication Critical patent/AU4373197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
AU43731/97A 1996-09-19 1997-09-19 Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof Abandoned AU4373197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2632096P 1996-09-19 1996-09-19
US60026320 1996-09-19
PCT/CA1997/000690 WO1998012227A1 (en) 1996-09-19 1997-09-19 Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof

Publications (1)

Publication Number Publication Date
AU4373197A true AU4373197A (en) 1998-04-14

Family

ID=21831158

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43731/97A Abandoned AU4373197A (en) 1996-09-19 1997-09-19 Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof

Country Status (2)

Country Link
AU (1) AU4373197A (en)
WO (1) WO1998012227A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2371803A (en) * 1999-11-18 2002-08-07 Oxford Biomedica Ltd Antibodies
AU1290001A (en) * 1999-11-18 2001-05-30 Oxford Biomedica (Uk) Limited Antibodies
AU2002304640A1 (en) * 2001-09-06 2003-03-24 Adnagen Ag Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
US8435529B2 (en) 2002-06-14 2013-05-07 Immunomedics, Inc. Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
US9770517B2 (en) 2002-03-01 2017-09-26 Immunomedics, Inc. Anti-Trop-2 antibody-drug conjugates and uses thereof
US9745380B2 (en) 2002-03-01 2017-08-29 Immunomedics, Inc. RS7 antibodies
ATE417067T1 (en) 2002-03-01 2008-12-15 Immunomedics Inc RS7 ANTIBODIES
CN1965082A (en) * 2004-02-06 2007-05-16 尼莫克斯股份有限公司 Humanized antibody
US8715662B2 (en) 2009-02-05 2014-05-06 Oncoxx Biotech S.R.L. Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
CN107428837A (en) 2015-04-22 2017-12-01 免疫医疗公司 Isolation, Detection, Diagnosis and/or Characterization of Circulating TROP‑2 Positive Cancer Cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625613B2 (en) * 1988-01-05 1992-07-16 Novartis Ag Novel chimeric antibodies
DE69529649T2 (en) * 1994-03-17 2003-12-18 Merck Patent Gmbh ANTI-EGFR SINGLE CHAIN FVS AND ANTI-EGFR ANTIBODIES
US5591629A (en) * 1994-04-29 1997-01-07 Mayo Foundation For Medical Education & Research Monoclonal antibodies which promote central nervous system remyelination
AU694222B2 (en) * 1994-05-02 1998-07-16 Bernd Groner Bifunctional protein, preparation and use

Also Published As

Publication number Publication date
WO1998012227A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
AU1226297A (en) Basic protein composition, basic peptide composition and application thereof
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU2508499A (en) Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof
AU7718898A (en) Txu-7-pap immunotoxin and use thereof
GB9712317D0 (en) Composition, compound and use
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
AU7377698A (en) Conveyor with integrated self-actuating clamp
AU4373197A (en) Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
GB9718876D0 (en) Compound,composition and use
EP0632115A3 (en) Binder and coating composition, its preparation and its use.
AU8748798A (en) 4-aminoquinazoline derivatives
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU7495796A (en) Novel oligopeptides, the preparation and use thereof
AU4571997A (en) Resin-coated segment, and manufacture thereof
AU2251697A (en) Pavement marking material, pre- and aftertreatment thereof
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
AU5176299A (en) Compound, composition and use
AU5557698A (en) Novel calpaines, their preparation and use
AU1046799A (en) Compound, composition and use
AU3411999A (en) Novel rnase-like protein and its use
AU2093997A (en) Spreader
ZA9610510B (en) Novel peptides, the preparation and use thereof.
AU2750397A (en) Antibodies directed against dithiocarbamates
AU1906599A (en) Pancreatic-derived factors, and uses related thereto
AU3908299A (en) Cadherin-like polypeptides, methods and compositions related thereto